Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04412954 · ClinicalTrials.gov registry record · NA

Improving Cardiovascular Risk Factors in Black Young Adults

A NA study, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
256
Enrollment target

NCT04412954: Completed NA study, sponsored by Ohio State University.

NCT04412954 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 256 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04412954, a NA study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
256 participants
Enrollment target

Study Summary

The objectives of the study are to conduct a randomized controlled trial to test the efficacy of the Smartphone intervention on % weight loss and maintaining % weight loss at 6 and 12 months in a sample (N=256) of Black community college students who are overweight or obese, ages 18-25 years. Investigators will also examine mediating variables of the intervention on weight at 6 and 12 months, including adherence to self-monitoring, discrimination, and dietary and physical activity self-efficacy. In addition, investigators will explore potential moderators of weight loss at 6 months and 12 months, including depressive symptoms, ideal body image, and motivation.

Primary Outcome

Body weight will be measured in light clothing without shoes using the Tanita Body Scale (BS)

Interventions

  • BEHAVIORAL Smartphone + Text Messaging with Health Coach

Trial Details

FieldValue
Enrollment Target 256 participants
Start Date 2020-12-05
Est. Completion 2024-11-30
Phase NA
Ohio State University

552 total trials

What the finished NCT04412954 record still lists

NCT04412954 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which Smartphone + Text Messaging with Health Coach is the first listed.

NCT04412954 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04412954 about?

NCT04412954 is a clinical study titled "Improving Cardiovascular Risk Factors in Black Young Adults". The objectives of the study are to conduct a randomized controlled trial to test the efficacy of the Smartphone intervention on % weight loss and maintaining % weight loss at 6 and 12 months in a sample (N=256) of Black community college students who are overweight or obese, ages 18-25 years. Invest...

What is the current status of trial NCT04412954?

This trial is currently completed. It is a NA study. The enrollment target is 256 participants. The study started on 2020-12-05. Estimated completion is 2024-11-30.

What interventions are being tested in trial NCT04412954?

The interventions under investigation include: Smartphone + Text Messaging with Health Coach (BEHAVIORAL).

Who is sponsoring clinical trial NCT04412954?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04412954's enrollment target sits among peer trials

256 404th of 2000 higher than 1,594 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02464696 · 256 participants · NA

    Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

  • NCT03793062 · 256 participants

    Genetic and Epigenetic Basis of Chronic Wounds

  • NCT04322318 · 256 participants · Phase 2

    A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • NCT04468360 · 256 participants · Phase 2

    Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04412954, the US trial registry maintained by the National Library of Medicine. NCT04412954 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.